Obstetrics and Gynecology, The Aga Khan University, Karachi, Pakistan
Obstetrics and Gynecology, The Aga Khan University, Karachi, Pakistan.
BMJ Open. 2022 Sep 9;12(9):e059273. doi: 10.1136/bmjopen-2021-059273.
A maternal sepsis management bundle for resource-limited settings was developed through a synthesis of evidence and international consensus. This bundle, called 'FAST-M' consists of: Fluids, Antibiotics, Source control, assessment of the need to Transport/Transfer to a higher level of care and ongoing Monitoring (of the mother and neonate). The study aimed to adapt the FAST-M intervention including the bundle care tools for early identification and management of maternal sepsis in a low-resource setting of Pakistan and identify potential facilitators and barriers to its implementation.
The study was conducted at the Liaquat University of Medical and Health Sciences, which is a tertiary referral public sector hospital in Hyderabad.
A qualitative exploratory study comprising key informant interviews and a focus group discussion was conducted with healthcare providers (HCPs) working in the study setting between November 2020 and January 2021, to ascertain the potential facilitators and barriers to the implementation of the FAST-M intervention. Interview guides were developed using the five domains of the Consolidated Framework for Implementation Research: intervention characteristics, outer setting, inner setting, characteristics of the individuals and process of implementation.
Four overarching themes were identified, the hindering factors for implementation of the FAST-M intervention were: (1) Challenges in existing system such as a shortage of resources and lack of quality assurance; and (2) Clinical practice variation that includes lack of sepsis guidelines and documentation; the facilitating factors identified were: (3) HCPs' perceptions about the FAST-M intervention and their positive views about its execution and (4) Development of HCPs readiness for FAST-M implementation that aided in identifying solutions to potential hindering factors at their clinical setting.
The study has identified potential gaps and probable solutions to the implementation of the FAST-M intervention, with modifications for adaptation in the local context TRIAL REGISTRATION NUMBER: ISRCTN17105658.
通过综合证据和国际共识,为资源有限的环境开发了一种孕产妇脓毒症管理工具包。该工具包称为“FAST-M”,由以下内容组成:液体、抗生素、源头控制、评估是否需要转运/转移到更高水平的治疗和持续监测(母亲和新生儿)。本研究旨在调整 FAST-M 干预措施,包括用于早期识别和管理巴基斯坦资源匮乏环境中孕产妇脓毒症的工具包护理,确定实施该措施的潜在促进因素和障碍。
该研究在拉奎特大学医学和健康科学学院进行,该学院是位于海得拉巴的一家三级转诊公立部门医院。
2020 年 11 月至 2021 年 1 月期间,在研究环境中与医疗保健提供者(HCP)进行了一项定性探索性研究,包括关键信息访谈和焦点小组讨论,以确定实施 FAST-M 干预的潜在促进因素和障碍。访谈指南使用实施研究的综合框架的五个领域制定:干预措施特征、外部环境、内部环境、个体特征和实施过程。
确定了四个总体主题,实施 FAST-M 干预的障碍因素是:(1)现有系统中的挑战,如资源短缺和缺乏质量保证;和(2)临床实践差异,包括缺乏脓毒症指南和文件;确定的促进因素是:(3)HCP 对 FAST-M 干预的看法以及他们对其执行的积极看法;(4)HCP 为 FAST-M 实施做好准备,有助于在其临床环境中发现潜在障碍因素的解决方案。
该研究确定了实施 FAST-M 干预的潜在差距和可能的解决方案,并对其进行了调整,以适应当地环境。试验注册号:ISRCTN86310158。